Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
RLYB
Stock Latest News
Market News
Rallybio Stock (RLYB) Rockets 25% on a Recursion Pharmaceuticals Agreement
7h ago
RLYB
RXRX
Premium
Company Announcements
Rallybio Sells REV102 Program to Recursion Pharmaceuticals
7h ago
8K
RLYB
Premium
The Fly
Rallybio to sell interest in REV102 to Recursion Pharmaceuticals for up to $25M
8h ago
RLYB
RXRX
Premium
The Fly
Recursion Pharmaceuticals acquires full rights to hypophosphatasia drug REV102
8h ago
RLYB
RXRX
Premium
Company Announcements
Rallybio Finalizes Employment Agreement with CMO
11d ago
8K
RLYB
Premium
Company Announcements
Rallybio’s FNAIT Study: A Closer Look at HPA-1a Alloimmunization
12d ago
RLYB
Premium
Company Announcements
Rallybio’s Phase 2 Study on RLYB212: A Potential Game-Changer for Pregnant Women at Risk
12d ago
RLYB
Premium
The Fly
Rallybio initiates dosing in RLYB116 study
26d ago
RLYB
Premium
Company Announcements
Rallybio Elects New Directors at Shareholder Meeting
2M ago
8K
RLYB
Premium
Company Announcements
Rallybio Reports Q1 2025 Financial Results and Strategic Updates
2M ago
RLYB
Premium
The Fly
Rallybio reports Q1 EPS (21c), consensus (28c)
2M ago
RLYB
Premium
The Fly
Rallybio downgraded to Hold from Buy at JonesResearch
3M ago
RLYB
Premium
The Fly
Rallybio downgraded to In Line from Outperform at Evercore ISI
3M ago
RLYB
Premium
The Fly
Rallybio downgraded to Neutral from Buy at H.C. Wainwright
3M ago
RLYB
Premium
The Fly
Citizens JMP downgrades Rallybio on RLYB212 discontinuation
3M ago
RLYB
Premium
The Fly
Rallybio downgraded to Market Perform from Outperform at Citizens JMP
3M ago
RLYB
Premium
The Fly
Rallybio discontinues RLYB212 program
3M ago
RLYB
Premium
Ratings
Rallybio’s Promising Developments and Financial Stability Justify Buy Rating
4M ago
RLYB
Premium
Ratings
Rallybio’s Promising Financial Stability and Strategic Clinical Advancements Drive Buy Rating
4M ago
RLYB
Premium
Company Announcements
Rallybio Corporation Reports 2024 Financial Results and Progress
4M ago
RLYB
Premium
Ratings
Promising Developments and Financial Stability Support Buy Rating for Rallybio
4M ago
RLYB
Premium
The Fly
Rallybio reports Q4 EPS (25c), consensus (30c)
4M ago
JNJ
RLYB
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
